v3.24.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Assets    
Cash and cash equivalents $ 71,838 $ 91,187
Restricted cash 156,699 114,829
Loans receivable at fair value 2,728,515 2,962,352
Credit cards receivable held for sale 52,581 0
Capitalized software and other intangibles, net 92,045 114,735
Right of use assets - operating 9,666 21,105
Other assets 139,954 107,680
Total assets 3,251,298 3,411,888
Liabilities    
Secured financing 125,393 289,951
Asset-backed notes at fair value 1,386,695 1,780,005
Asset-backed borrowings at amortized cost 1,109,370 581,468
Acquisition and corporate financing 215,697 258,746
Lease liabilities 19,728 28,376
Other liabilities 66,859 68,938
Total liabilities 2,923,742 3,007,484
Stockholders' equity    
Common stock, $0.0001 par value - 1,000,000,000 shares authorized at September 30, 2024 and December 31, 2023; 36,243,060 shares issued and 35,971,037 shares outstanding at September 30, 2024; 34,741,076 shares issued and 34,469,053 shares outstanding at December 31, 2023 7 7
Common stock, additional paid-in capital 595,127 584,555
Accumulated deficit (261,269) (173,849)
Treasury stock at cost, 272,023 shares at September 30, 2024 and December 31, 2023 (6,309) (6,309)
Total stockholders’ equity 327,556 404,404
Total liabilities and stockholders' equity $ 3,251,298 $ 3,411,888

Source